These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 14563912)

  • 1. An economic assessment of pre-vaccination screening for hepatitis A and B.
    Jacobs RJ; Saab S; Meyerhoff AS; Koff RS
    Public Health Rep; 2003; 118(6):550-8. PubMed ID: 14563912
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cost-effective analysis of hepatitis A prevention in Ireland.
    Rajan E; Shattock AG; Fielding JF
    Am J Gastroenterol; 2000 Jan; 95(1):223-6. PubMed ID: 10638588
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cost-effectiveness of hepatitis A/B vaccine versus hepatitis B vaccine in public sexually transmitted disease clinics.
    Jacobs RJ; Meyerhoff AS
    Sex Transm Dis; 2003 Nov; 30(11):859-65. PubMed ID: 14603096
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cost-effectiveness analysis of vaccination against hepatitis A in travellers.
    Van Doorslaer E; Tormans G; Van Damme P
    J Med Virol; 1994 Dec; 44(4):463-9. PubMed ID: 7897383
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The prevalence of hepatitis A antibodies among Israeli travellers and the economic feasibility of screening before vaccination.
    Schwartz E; Raveh D
    Int J Epidemiol; 1998 Feb; 27(1):118-20. PubMed ID: 9563704
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cost effectiveness of hepatitis B vaccination at HIV counseling and testing sites.
    Kim SY; Billah K; Lieu TA; Weinstein MC
    Am J Prev Med; 2006 Jun; 30(6):498-506. PubMed ID: 16704944
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cost-effectiveness analysis of hepatitis A vaccination strategies for adults.
    O'Connor JB; Imperiale TF; Singer ME
    Hepatology; 1999 Oct; 30(4):1077-81. PubMed ID: 10498662
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cost effectiveness of hepatitis A prevention in France.
    Severo CA; Fagnani F; Lafuma A
    Pharmacoeconomics; 1995 Jul; 8(1):46-61. PubMed ID: 10155601
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A reappraisal of hepatitis B virus vaccination strategies using cost-effectiveness analysis.
    Bloom BS; Hillman AL; Fendrick AM; Schwartz JS
    Ann Intern Med; 1993 Feb; 118(4):298-306. PubMed ID: 8420448
    [TBL] [Abstract][Full Text] [Related]  

  • 10. What type of travelers would benefit from combined vaccination against hepatitis A and B?
    Iwarson S
    J Travel Med; 1998 Jun; 5(2):80-3. PubMed ID: 9925432
    [No Abstract]   [Full Text] [Related]  

  • 11. The cost-effectiveness of vaccinating chronic hepatitis C patients against hepatitis A.
    Jacobs RJ; Koff RS; Meyerhoff AS
    Am J Gastroenterol; 2002 Feb; 97(2):427-34. PubMed ID: 11866283
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exposure to hepatitis B virus among South African health care workers--implications for pre-immunisation screening.
    Schoub BD; Johnson S; McAnerney J; Blackburn NK; Padayachee GN
    S Afr Med J; 1991 Jan; 79(1):27-9. PubMed ID: 1824730
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cost effectiveness of hepatitis A/B versus hepatitis B vaccination for US prison inmates.
    Jacobs RJ; Rosenthal P; Meyerhoff AS
    Vaccine; 2004 Mar; 22(9-10):1241-8. PubMed ID: 15003653
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Economic evaluation of a 2-dose hepatitis B vaccination regimen for adolescents.
    Levaux HP; Schonfeld WH; Pellissier JM; Cassidy WM; Sheriff SK; Fitzsimon C
    Pediatrics; 2001 Aug; 108(2):317-25. PubMed ID: 11483794
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The cost effectiveness of hepatitis immunization for US college students.
    Jacobs RJ; Saab S; Meyerhoff AS
    J Am Coll Health; 2003 May; 51(6):227-36. PubMed ID: 14510025
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Testing for antibody to hepatitis A to decrease the cost of hepatitis A prophylaxis with immune globulin or hepatitis A vaccines.
    Bryan JP; Nelson M
    Arch Intern Med; 1994 Mar; 154(6):663-8. PubMed ID: 8129500
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An economic analysis of different strategies of immunization against hepatitis A virus in developed countries.
    Das A
    Hepatology; 1999 Feb; 29(2):548-52. PubMed ID: 9918934
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Indications for use of hepatitis B vaccine, based on cost-effectiveness analysis.
    Mulley AG; Silverstein MD; Dienstag JL
    N Engl J Med; 1982 Sep; 307(11):644-52. PubMed ID: 6810170
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cost effectiveness of antenatal hepatitis B screening and vaccination of infants.
    Thomas IL
    Aust N Z J Obstet Gynaecol; 1990 Nov; 30(4):331-5. PubMed ID: 2150586
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preventing hepatitis A infections in travelers to endemic areas.
    Koff RS
    Am J Trop Med Hyg; 1995 Dec; 53(6):586-90. PubMed ID: 8561258
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.